<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Pharmacology - INI CET MAY 2022</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Pharmacology - INI CET MAY 2022</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                15 Questions | 15 Total Marks | 25 min Duration | ~100.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 15 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 25 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 15</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Pharmacology - INI CET MAY 2022 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 15</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 15 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following factor in PC VS time graph is a measure of extent of drug absorption of a drug?", "options": [{"label": "A", "text": "Area under the Curve", "correct": true}, {"label": "B", "text": "Half Line", "correct": false}, {"label": "C", "text": "Cmax", "correct": false}, {"label": "D", "text": "Tmax", "correct": false}], "correct_answer": "A. Area under the Curve", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Area under the Curve</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option D - Tmax - time taken to reach max concentration - correlates with Rate of absorption. Option C - Cmax - maximum concentration at a given dose ‚Äì correlates with maximum concentration achieved at any dose. Option B - Half Life ‚Äì time taken for half the drug to eliminate ‚Äì correlates with rate of elimination. Area under the curve gives us the extent of drug absorption.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Manufacturer of a drug company labels the drug contains 500 mg Paracetamol. On quantitative analysis by the authorities, it was found to contain only 200 mg of drug. According to drugs and cosmetics act 1940, this type of drug is known as?", "options": [{"label": "A", "text": "Spurious Drug", "correct": false}, {"label": "B", "text": "Adulterant Drug", "correct": false}, {"label": "C", "text": "Unethical Drug", "correct": false}, {"label": "D", "text": "Misbranded Drug", "correct": true}], "correct_answer": "D. Misbranded Drug", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Misbranded Drug Misbranded drug: Any wrong information on the label or in other words, any drug for which the label is in any way false or misleading. Such conduct as set forth in paragraphs (1) and (2) of the Findings of Fact Section constitutes a violation of section 3715.64(A).</p>\n<p><strong>Highyeild:</strong></p><p>Characteristics of Misbranded drugs in India Not labelled in the prescribed manner Colored, coated & polished that damage is concealed Appears better and of greater therapeutic value than what actually is Label or container accompanying the drugs bears statement which makes false claim for the drug and which is misleading</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A - Spurious drug: Mimicking drug of a well reputed producer Spurious or imitation drug products are drug formulations manufactured concealing the true identity of the product and made to resemble another drug, especially some popular brand, to deceive the buyer and cash on the popularity of original product. The product may or may not contain the active ingredients. Option B - Adulterated drug: Substituting original crude drug with other similar looking substances A drug or device shall be deemed to be adulterated if it is a drug and any substance has been (i) mixed or packed with it so as to reduce its quality or strength or (ii) substituted wholly or in part for it. Option C - No term such as unethical drug exists</p>\n<p><strong>Table:</strong></p><p>#MANTRA Misbranded drugs. - Label related to Warning Directions to use Claim if it is not labelled in the prescribed manner; or if its label or container or anything accompanying the drug design or device which makes any false claim for the drug or which is false or misleading in any particular. if it is so coloured, coated, powdered or polished that damage is concealed or if it is made to appear of better or greater therapeutic value than it really is;</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following statement is correct regarding the given graph?", "options": [{"label": "A", "text": "Drug A represent agonist and Drug B represents inverse agonist", "correct": false}, {"label": "B", "text": "Drug C represents agonist and Drug D is inverse agonist", "correct": false}, {"label": "C", "text": "Drug A is agonist and Drug D is inverse agonist", "correct": true}, {"label": "D", "text": "Drug B is partial agonist and Drug C is inverse agonist", "correct": false}], "correct_answer": "C. Drug A is agonist and Drug D is inverse agonist", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1692796171795-QTDJPYQ260IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Drug A is agonist and Drug D is inverse agonist Graph shows percentage of Maximum activity or intrinsic activity.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A - drug B is not inverse agonist , it is partial agonist. Partial agonists have a lower intrinsic activity at receptors than full agonists, allowing them to act either as a functional agonist or a functional antagonist, depending on the surrounding levels of naturally occurring neurotransmitter (full agonist). Option B - drug C do not have any activity irrespective of the ligand concentration - so it is not likely to be an agonist. Option D - drug C do not have any activity irrespective of the ligand concentration - so it is not likely to be a partial agonist. Based on this there are 4 types of intrinsic activity given the graph: Agonist 1 Partial Agonist 0-1 Antagonist 0 Inverse Agonist -ve Drug A has maximum activity and Drug D is negative hence Option C is the correct answer.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Identify the type of inhibition from the given graph?", "options": [{"label": "A", "text": "Competitive", "correct": true}, {"label": "B", "text": "Non-Competitive", "correct": false}, {"label": "C", "text": "Un-Competitive", "correct": false}, {"label": "D", "text": "Allosteric", "correct": false}], "correct_answer": "A. Competitive", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Competitive The given graph is a LINEWEAVER BURKE PLOT between 1/V and 1/S</p>\n<p><strong>Highyeild:</strong></p><p>Competitive inhibition is interruption of a chemical pathway owing to one chemical substance inhibiting the effect of another by competing with it for binding or bonding. An example of a competitive inhibitor is the antineoplastic drug methotrexate. Methotrexate has a structure similar to that of the vitamin folic acid. It acts by inhibiting the enzyme dihydrofolate reductase, preventing the regeneration of dihydrofolate from tetrahydrofolate. Noncompetitive inhibition, a type of allosteric regulation, is a specific type of enzyme inhibition characterized by an inhibitor binding to an allosteric site resulting in decreased efficacy of the enzyme. An allosteric site is simply a site that differs from the active site- where the substrate binds. The inhibitory effects of heavy metals, and of cyanide on cytochrome oxidase and of arsenate on glyceraldehyde phosphate dehydrogenase, are examples of non-competitive inhibition. This type of inhibitor acts by combining with the enzyme in such a way that for some reason the active site is rendered inoperative. In Competitive inhibition Vmax remains the same while Km changes In noncompetitive inhibition Km remains the same while Vmax changes Reversible uncompetitive inhibition occurs when (I) binds only to the enzyme-substrate complex (ES) and not free E. One can hypothesize that on binding S, a conformational change in E occurs which presents a binding site for I. Inhibition occurs since ESI cannot form product. In un competitive inhibition both Km and Vmax remains different.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 20 year old boy was brought to emergency room after consuming some unknown substance. The patient was sweating profusely, saliva was drooling from mouth and tears were present. The boy suffered involuntary urination and diarrhea. On examination, the heart rate was 58 beats per minutes and blood pressure was 80/60 mm hg. Which of the following is the drug of choice for the treatment of this patient?", "options": [{"label": "A", "text": "Atropine", "correct": true}, {"label": "B", "text": "N-Acetylcysteine", "correct": false}, {"label": "C", "text": "Naloxone", "correct": false}, {"label": "D", "text": "Physostigmine", "correct": false}], "correct_answer": "A. Atropine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Atropine This clinical scenario is suggestive of Mushroom poisoning or Organophosphate poisoning with cholinergic symptoms. Atropine is the DOC in organophosphate poisoning. Antidotes: Atropine ‚Äì OP poisoning N acetylcysteine ‚Äì Paracetamol overdose Naloxone ‚Äì Opiod poisoning Physostigmine - Atropine Organophosphate poisoning permanently block the AchE and thus increase Ach which leads to various muscarinic effects M1: Increases gastric HCl M2 : CVS effectsü°™decreases HR and BP M3 : Pinpoint pupils, Increased secretions (Severe diarrhea), Urinary incontinence, Broncho-constriction . <</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B - NAC - N-acetylcysteine is a medication used to treat conditions such as asthma and cystic fibrosis. As an inhalant, it helps to thin mucus and make it less paste-like. It also reduces inflammation. N-acetylcysteine is byproduct of glutathione . Option C - naloxone - Naloxone, sold under the brand name Narcan among others, is a medication used to reverse the effects of opioids. It is commonly used to counter decreased breathing in opioid overdose. Effects begin within two minutes when given intravenously, and within five minutes when injected into a muscle. Option D - Physostigmine is a medication most commonly used to manage and treat antimuscarinic toxicity and glaucoma. It is a tertiary amine and a reversible cholinergic medication most commonly used to manage and treat antimuscarinic toxicity and glaucoma.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not the primary treatment agent in rheumatoid arthritis?", "options": [{"label": "A", "text": "Methotrexate", "correct": false}, {"label": "B", "text": "Hydroxychloroquine", "correct": false}, {"label": "C", "text": "Sulfasalazine", "correct": false}, {"label": "D", "text": "Azathioprine", "correct": true}], "correct_answer": "D. Azathioprine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Azathioprine</p>\n<p><strong>Highyeild:</strong></p><p>DMARD Use with Hepatic Disease Contraindicated with Hepatic Disease ‚óè     MTX ‚óè     Leflunomide ‚óè     NSAIDS ‚óè     Acetaminophen ‚óè     Azathioprine ‚óè     Sulfasalazine Contraindicated with HBV ‚óè     Rituximab ‚óè     TNF inhibitors ‚óè     Abatacept Probably Safe in HCV ‚óè     Glucocorticoids ‚óè     Hydroxychloroquine ‚óè     TNF inhibitors ‚óè     Gold Salts ‚óè     Mycophenolate ‚óè     Cyclosporine Common DMARDs include methotrexate (Trexall, Otrexup, others), leflunomide (Arava), hydroxychloroquine (Plaquenil) and sulfasalazine (Azulfidine). Side effects vary but may include liver damage and severe lung infections. Azathioprine is an immune suppressive agent and is rarely used in RA.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A - DOC in RA (rheumatoid arthritis) is Methotrexate. Methotrexate is one of a group of medications called disease‚Äêmodifying antirheumatic drugs (DMARDs) and it is the most common treatment for rheumatoid arthritis. Methotrexate helps prevent further permanent damage that can happen if rheumatoid arthritis is not treated. Option B - DOC in RA during pregnancy is Hydroxychloroquine Hydroxychloroquine has been available since the 1970s and is used widely for the treatment of lupus (SLE) but is also an established drug for the treatment of mild RA. It is commonly used in combination with one or two other disease modifying anti-rheumatic drugs (DMARDs), particularly methotrexate. Option C - Sulfasalazine is second line drug in RA. Sulfasalazine, sold under the trade name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn